Solutions Ecosystems Reports Resources Data Pricing Login Book a demo

Biotech & Life Sciences

Drug discovery, gene editing, synthetic biology

Companies inventing new medicines and biological technologies — gene therapies, mRNA platforms, synthetic biology, computational drug discovery. Long timelines, immense upside. · A public taster of the full Dealroom platform — request a demo for live deal flow, founder pedigrees, AI-talent maps, and per-company financials.

1.1 Overview

$1.1T+28%
Combined startup EV
9,200
Tracked startups
220
Thoroughbreds ($100M rev+)
2.4% of startups
158
Unicorns ($1B+)
1.7% of startups
9
Decacorns ($10B+)
5.7% of unicorns

1.2 🔥 Hottest sub-segments

What's heating up inside Biotech & Life Sciences

Top 12 of 39 Biotech & Life Sciences sub-sectors ranked by Dealroom's curated signal score (combines funding velocity, unicorn formation, recency).

#1
Neurology
+86% VC growth42 unicorns · $283B EV
#2
Drug Development
+98% VC growth107 unicorns · $595B EV
#3
Radiology
+341% VC growth2 unicorns · $24.2B EV
#4
Oncology
+58% VC growth163 unicorns · $1.1T EV
#5
Health » Pharmaceutical
+101% VC growth199 unicorns · $1.6T EV
#6
Health » Biotechnology
+87% VC growth465 unicorns · $3.5T EV
#7
Chronic Disease
+104% VC growth10 unicorns · $81.1B EV
#8
AI Drug Discovery
+163% VC growth23 unicorns · $105B EV
#9
Diabetes
+63% VC growth25 unicorns · $191B EV
#10
Immune System
+49% VC growth19 unicorns · $117B EV
#11
Biomarkers
+67% VC growth2 unicorns · $11.2B EV
#12
Autoimmune
+48% VC growth9 unicorns · $47.2B EV

Heat ranking from venture-sector-lens — Dealroom's curated 0–100 sector signal combining funding velocity, unicorn formation, and emergence.

3.1 Rounds & valuations

Largest Biotech & Life Sciences rounds & most valuable companies

A live treemap of $100M+ rounds — or switch the view to size companies by their latest valuation (EV). Filter by HQ region; drag the year slider to add earlier rounds.

Largest Biotech & Life Sciences rounds - Global 2026

Every $100M+ VC round classified as Biotech & Life Sciences in 2026, grouped by company HQ location.
- rounds · - raised
Location
Live from Dealroom API Open full VC dashboard

3.2 VC investment

When the capital landed in Biotech & Life Sciences

VC investment into Biotech & Life Sciences companies over the last decade, broken down by round size, company location, sector and funding stage. Counts VC rounds into companies tagged or classified to Biotech & Life Sciences. Live from the Dealroom Next Gen API.

4.1 Geographic concentration

Where Biotech & Life Sciences startups concentrate

Cities and countries ranked by Biotech & Life Sciences unicorns headquartered there, plus countries that over-index the global average (5× = 5× more represented than globally).

5.1 Sector comparison

How Biotech & Life Sciences stacks up

Compare Biotech & Life Sciences with the other simplified sectors — switch between combined EV, 5-year EV growth, and a growth × size view. Expand the table for every sector.

$3.5T
$1.9T
Biotech & Life Sciences
$1.1T
$920B

Combined enterprise value of each sector.

5.2 Premium analytics

What we don't show on this page (yet)

Founder origins, AI-talent leaderboards, live deal flow and the patent landscape are gated to logged-in Dealroom users. Book a demo to access the full Biotech & Life Sciences dataset.

Founder origins
Where Biotech & Life Sciences founders went to school
Top universities
Origin countries
Origin companies
Per-capita map
Unlock on Dealroom
AI talent in Biotech & Life Sciences
Top employers of AI talent in Biotech & Life Sciences
Core AI roles
Frontier AI roles
YoY hiring growth
Senior + lead engineers
Unlock on Dealroom
Deal flow
Live Biotech & Life Sciences deal flow & funding rounds
New rounds last 30 days
Stage breakdown
Active investors
Round-size trends
Unlock on Dealroom
Patent map
Biotech & Life Sciences patent landscape
Top patent filers
Tech-cluster map
Citations & influence
Filing velocity
Unlock on Dealroom

5.3 Market sentiment

What the market is saying about Biotech & Life Sciences

An AI-synthesized read of the highest-engagement posts about Biotech & Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

Get the full Biotech & Life Sciences sector on Dealroom

Live deal flow, founder pedigree, hiring signals and revenue trajectories — for every Biotech & Life Sciences startup.